• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荟萃分析:肝硬化患者早期肝细胞癌的超声监测。

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.

机构信息

Division of Gastroenterology, Department of Internal Medicine, University of Michigan, Ann Arborr, MI 48109, USA.

出版信息

Aliment Pharmacol Ther. 2009 Jul;30(1):37-47. doi: 10.1111/j.1365-2036.2009.04014.x. Epub 2009 Apr 8.

DOI:10.1111/j.1365-2036.2009.04014.x
PMID:19392863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6871653/
Abstract

BACKGROUND

A majority of studies investigating the accuracy of ultrasound for detecting hepatocellular carcinoma (HCC) do not reflect how this test is used for surveillance vs. diagnosis.

AIM

To determine the performance characteristics of surveillance with ultrasound for the detection of HCC, particularly early HCC as defined by the Milan criteria.

METHODS

A systematic literature review using the MEDLINE and SCOPUS databases yielded six studies that evaluated the accuracy of ultrasound for HCC at any stage and 13 studies that were specific to early HCC.

RESULTS

Surveillance ultrasound detected the majority of tumours before they presented clinically, with a pooled sensitivity of 94%. However, ultrasound was less effective for detecting early HCC with a sensitivity of 63%. Alpha-fetoprotein provided no additional benefit to ultrasound. Meta-regression analysis demonstrated a significantly higher sensitivity for early HCC with ultrasound every 6 months than with annual surveillance. Current studies have limitations such as verification bias and are of suboptimal quality.

CONCLUSIONS

Surveillance with ultrasound demonstrates limited sensitivity for early HCC, although this may be improved by testing at 6-month intervals. Currently available evidence evaluating surveillance ultrasound has significant limitations and future studies are necessary to determine optimal surveillance methods for early HCC.

摘要

背景

大多数研究调查了超声检测肝细胞癌 (HCC) 的准确性,但并未反映该检测在监测与诊断方面的应用情况。

目的

旨在确定超声监测 HCC 检测的性能特征,特别是根据米兰标准定义的早期 HCC。

方法

使用 MEDLINE 和 SCOPUS 数据库进行系统文献综述,共获得了 6 项评估任何阶段 HCC 超声准确性的研究,以及 13 项专门针对早期 HCC 的研究。

结果

监测性超声在肿瘤出现临床症状前多数可检测到,其总体敏感性为 94%。然而,超声对早期 HCC 的检测效果较差,敏感性为 63%。甲胎蛋白对超声检查没有额外的帮助。Meta 回归分析显示,每 6 个月而非每年进行超声监测的早期 HCC 敏感性更高。目前的研究存在验证偏倚等局限性,且质量欠佳。

结论

尽管每 6 个月检测可提高超声监测早期 HCC 的敏感性,但监测性超声对早期 HCC 的敏感性有限。目前评估监测性超声的证据存在显著局限性,需要进一步研究来确定早期 HCC 的最佳监测方法。

相似文献

1
Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis.荟萃分析:肝硬化患者早期肝细胞癌的超声监测。
Aliment Pharmacol Ther. 2009 Jul;30(1):37-47. doi: 10.1111/j.1365-2036.2009.04014.x. Epub 2009 Apr 8.
2
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.肝硬化患者肝细胞癌早期检测的监测成像和甲胎蛋白:一项荟萃分析。
Gastroenterology. 2018 May;154(6):1706-1718.e1. doi: 10.1053/j.gastro.2018.01.064. Epub 2018 Feb 6.
3
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.肝细胞癌肝硬化监测:系统评价与经济分析
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.
4
Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis.肝硬化患者肝癌监测的效果。
Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):793-9. doi: 10.1158/1055-9965.EPI-11-1005. Epub 2012 Feb 28.
5
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.在非病毒性肝硬化患者中,利用血清甲胎蛋白检测和腹部超声进行肝细胞癌筛查比单纯使用超声更有效。
J Gastrointest Cancer. 2018 Dec;49(4):476-480. doi: 10.1007/s12029-017-0006-y.
6
Annual contrast-enhanced magnetic resonance imaging is highly effective in the surveillance of hepatocellular carcinoma among cirrhotic patients.年度对比增强磁共振成像在肝硬化患者肝癌监测中具有高度有效性。
Eur J Gastroenterol Hepatol. 2020 Apr;32(4):517-523. doi: 10.1097/MEG.0000000000001528.
7
Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta-analysis.多靶点血液检测与超声及甲胎蛋白用于肝细胞癌监测的比较:一项网络荟萃分析的结果。
Hepatol Commun. 2022 Oct;6(10):2925-2936. doi: 10.1002/hep4.2045. Epub 2022 Aug 9.
8
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis.影响肝硬化患者早期肝细胞癌超声监测疗效的因素。
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1927-33.e2. doi: 10.1016/j.cgh.2014.02.025. Epub 2014 Feb 26.
9
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis.甲胎蛋白、超声、计算机断层扫描和磁共振成像用于检测晚期肝硬化患者的肝细胞癌。
Aliment Pharmacol Ther. 2007 Nov 1;26(9):1187-94. doi: 10.1111/j.1365-2036.2007.03498.x.
10
Ultrasonographic and radionuclide detection of hepatocellular carcinoma in cirrhotics with low alpha-fetoprotein levels.超声及放射性核素检测甲胎蛋白水平低的肝硬化患者中的肝细胞癌
Cancer. 1984 Dec 15;54(12):2924-6. doi: 10.1002/1097-0142(19841215)54:12<2924::aid-cncr2820541218>3.0.co;2-f.

引用本文的文献

1
Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma.基于转化生长因子-β信号通路的血清蛋白质组学特征可对肝细胞癌风险进行分层。
Liver Int. 2025 Oct;45(10):e70325. doi: 10.1111/liv.70325.
2
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.肝细胞癌的当代流行病学:了解风险因素和监测策略。
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
3
Comparative Analysis of Imaging Modalities for Surveillance on Outcomes in Patients With Hepatocellular Carcinoma.肝细胞癌患者预后监测成像方式的比较分析
Gastro Hep Adv. 2025 May 16;4(9):100704. doi: 10.1016/j.gastha.2025.100704. eCollection 2025.
4
Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy.意大利人工智能(AI)在早期检测有肝细胞癌风险的肝硬化患者肝脏病变中的成本效益分析。
J Med Econ. 2025 Dec;28(1):1023-1036. doi: 10.1080/13696998.2025.2525006. Epub 2025 Jul 11.
5
Abbreviated MRI-Based Surveillance Strategies for Early Hepatocellular Carcinoma Detection.基于磁共振成像(MRI)的简化监测策略用于早期肝细胞癌检测
J Korean Soc Radiol. 2025 May;86(3):335-351. doi: 10.3348/jksr.2024.0153. Epub 2025 May 26.
6
Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey.年轻胃肠病学家的腹部及肠道超声知识:一项意大利调查的结果
J Clin Med. 2025 Apr 15;14(8):2693. doi: 10.3390/jcm14082693.
7
Effectiveness of noncontrast-abbreviated magnetic resonance imaging in a real-world hepatocellular carcinoma surveillance.非增强简化磁共振成像在真实世界肝细胞癌监测中的有效性
Eur Radiol. 2025 Mar 20. doi: 10.1007/s00330-025-11517-0.
8
Optimizing Hepatocellular Carcinoma Screening: A Comparative Simulated Abbreviated MRI Protocol Study.优化肝细胞癌筛查:一项比较性模拟简化磁共振成像方案研究。
Cureus. 2025 Feb 7;17(2):e78711. doi: 10.7759/cureus.78711. eCollection 2025 Feb.
9
Recent advances and issues in imaging modalities for hepatocellular carcinoma surveillance.肝细胞癌监测成像方式的最新进展与问题
J Liver Cancer. 2025 Mar;25(1):31-40. doi: 10.17998/jlc.2025.02.16. Epub 2025 Feb 26.
10
A concise review of updated global guidelines for the management of hepatocellular carcinoma: 2017-2024.肝细胞癌管理全球最新指南(2017 - 2024年)简明综述
J Liver Cancer. 2025 Mar;25(1):19-30. doi: 10.17998/jlc.2025.02.03. Epub 2025 Feb 10.

本文引用的文献

1
Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.肝细胞癌的肝移植:终末期肝病模型(MELD)分配系统的影响及生存预测因素
Gastroenterology. 2008 May;134(5):1342-51. doi: 10.1053/j.gastro.2008.02.013. Epub 2008 Feb 13.
2
Application of summary receiver operating characteristics (sROC) analysis to diagnostic clinical testing.汇总受试者工作特征(sROC)分析在诊断性临床检测中的应用。
Adv Med Sci. 2007;52:76-82.
3
Computed tomography--an increasing source of radiation exposure.计算机断层扫描——辐射暴露的一个日益增加的来源。
N Engl J Med. 2007 Nov 29;357(22):2277-84. doi: 10.1056/NEJMra072149.
4
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives.《1975 - 2004年美国癌症现状年度报告:聚焦美国印第安人和阿拉斯加原住民的癌症情况》
Cancer. 2007 Nov 15;110(10):2119-52. doi: 10.1002/cncr.23044.
5
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.肝细胞癌:流行病学与分子致癌机制
Gastroenterology. 2007 Jun;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061.
6
Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century.肝细胞癌:20世纪末欧美地区的发病率及生存率趋势
Am J Gastroenterol. 2007 Aug;102(8):1661-70; quiz 1660, 1671. doi: 10.1111/j.1572-0241.2007.01337.x. Epub 2007 Jun 6.
7
The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.丙型肝炎病毒所致代偿期肝硬化的自然史:一项对214例患者的17年队列研究。
Hepatology. 2006 Jun;43(6):1303-10. doi: 10.1002/hep.21176.
8
Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review.超声检查、螺旋CT、磁共振成像及甲胎蛋白诊断肝细胞癌的准确性:一项系统评价
Am J Gastroenterol. 2006 Mar;101(3):513-23. doi: 10.1111/j.1572-0241.2006.00467.x.
9
Management of hepatocellular carcinoma.肝细胞癌的管理
Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933.
10
Screening tests for hepatocellular carcinoma.肝细胞癌的筛查试验
Clin Liver Dis. 2005 May;9(2):235-51, vi. doi: 10.1016/j.cld.2004.12.006.